512529 — Viyash Scientific Share News
0.000.00%
Last trade - 00:00- IN₹109.09bn
- IN₹113.45bn
- IN₹34.20bn
Brief: Sequent Scientific Dec-qtr consol loss narrows
Brief: Sequent Scientific unit to acquire Topkim, Turkey
Brief: Sequent Scientific's Mangalore facility gets establishment inspection report from USFDA
Brief: Sequent Scientific approves sub-division of equity shares
Gilead signs hepatitis C pact to cut drug cost for poor (updated)
Gilead licenses hepatitis C drug to Cipla, Ranbaxy, 5 others